<DOC>
	<DOCNO>NCT02923310</DOCNO>
	<brief_summary>OOsteoarthritis ( OA ) chronic joint disease characterize progressive degeneration cartilage bone tissue , lead appearance subchondral cyst , osteophyte formation synovial inflammation . Although cause OA still poorly understood , biomechanical stress able reach articular cartilage subchondral bone , biochemical change cartilage synovial membrane , well genetic factor important item pathogenesis . Although cure OA , treatment direct individual patient , seek minimize pain , maintain improve joint range motion limit disability . New therapy able accelerate regeneration tissue repair process discuss . The viscosupplementation hyaluronic acid ( HA ) show effective safe treatment alternative fight knee OA , addition HA , worth highlight therapeutic effect growth factor derive autologous platelet . The platelet-rich plasma ( PRP ) appear autologous therapy , non-immunogenic , able induce heal repair bone soft tissue . This study aim evaluate clinical efficacy , compare treatment PRP combination HA PRP treatment knee OA . To , 120 select OA patient mild , moderate severe ( Grade II , III IV ) . Selected patient scheduled procedure randomly assign randomly . In PRP determine concentration growth factor PDGF , TGFb 1 , VEGF , EGF , method Bio Plex®.\ . Functional evaluation conduct questionnaire ( WOMAC SF-36 ) measure function quality self-reported life . The walking strength test perform period 90.180 360 day first application . The main motivation development study lack randomize , double-blind clinical study literature , also base favorable result researcher obtain , use HA , use PRP accelerate process scar , prevent development arthrosis . Therefore , believe PRP , growth factor associate synthetic HA play synergistic action study detail , order establish effective therapeutic approach treatment patient knee OA .</brief_summary>
	<brief_title>Evaluation Two Types PRP Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<criteria>Patients Osteoarthrits diabetes , rheumatoid arthritis , axial deviation ( varus &gt; 10 degree valgus &gt; 10 degree ) , blood disorder ( coagulopathy platelet change ) , cardiovascular disease , infection , immunosuppression , patient anticoagulant therapy antiplatelet use nonsteroidal antiinflammatory 5 day blood collection , patient hemoglobin concentration &lt; 11 platelet count &lt; 150,000 mm³ .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>